Cookies are essential for the operation of our website. By using our website, you agree to the use of cookies.
This website uses cookies to improve and personalize content, and for tracking and analytics. By clicking "Accept All Cookies", you are providing consent for Exelixis to collect and retain personal data for Exelixis to optimize the use of this website. You can learn more about Exelixis' use of cookies by reviewing Exelixis' Privacy Statement.
Reject Nonessential Cookies Accept All Cookies
Skip to main content

Disable motion

Medical
Affairs

Exelixis Medical Affairs is committed to scientific innovation, education, communication, and research.

Cabozantinib
Development Program

Cabozantinib Development Program

Explore
Our Pipeline

Explore our pipeline

About
Medical Affairs

Click to go to Resource

Explore Our
Clinical Trials

Clinical Trials